Key result
Neo-adjuvant chemotherapy with the MAID regimen enabled complete resection of an initially unresectable retroperitoneal malignant fibrous histiocytoma, resulting in over 5 years of recurrence-free survival.
Why the study?
Does neo-adjuvant MAID chemotherapy followed by en bloc resection improve survival and prevent recurrence in a patient with initially unresectable retroperitoneal malignant fibrous histiocytoma?
Case Report (n=1)
No
Does neo-adjuvant MAID chemotherapy followed by en bloc resection improve survival and prevent recurrence in a patient with initially unresectable retroperitoneal malignant fibrous histiocytoma?
Neo-adjuvant MAID chemotherapy followed by en bloc resection may be an effective treatment strategy for initially unresectable retroperitoneal malignant fibrous histiocytoma, leading to long-term recurrence-free survival.
May support neoadjuvant MAID in select unresectable retroperitoneal MFH; hypothesis-generating and requires prospective validation.
Malignant fibrous histiocytoma (MFH) is most commonly observed in the extremities and the trunk but rarely in retroperitoneum. The present case report documents a 64‑year‑old man who was admitted with an abdominal palpable mass for 6 months. After a thorough investigation, a tumor of the retroperitoneum was identified adhered to adjacent organs and vessels. The patient experienced mild hydronephrosis and hydroureter as a result of the tumor compression. A number of previous surgeons considered the tumor unresectable and suggested palliative treatment. En bloc resection of the tumor was attempted but incomplete surgery was performed initially as the tumor was friable and prone to bleeding. Therefore, a biopsy of the tumor was performed and a double J ureteral stent was set for hydronephrosis. Histopathological examination confirmed the tumor was an MFH. The patient received neo‑adjuvant chemotherapy with 4 cycles of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID). A computed tomography scan demonstrated that the tumor had reduced in size following chemotherapy. En bloc resection of the tumor was arranged again 6 months later. The tumor exhibited a complete response to neo‑adjuvant chemotherapy after the formal pathological evaluation. The patient survives without tumor recurrence >5 years without recurrence.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2016) conducted a case report in Retroperitoneal malignant fibrous histiocytoma (n=1). Neo-adjuvant chemotherapy (MAID regimen) and en bloc resection was evaluated on Tumor response and recurrence. Neo-adjuvant chemotherapy with the MAID regimen enabled complete resection of an initially unresectable retroperitoneal malignant fibrous histiocytoma, resulting in over 5 years of recurrence-free survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: